ACE2 SARS-CoV2-mediated valve disease in a microphysiological tissue-chip model
微生理组织芯片模型中的 ACE2 SARS-CoV2 介导的瓣膜疾病
基本信息
- 批准号:10438067
- 负责人:
- 金额:$ 43.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoV3-DimensionalACE2Amino AcidsArkansasArrhythmiaBiomedical ResearchCOVID-19COVID-19 patientCardiac MyocytesCardiovascular systemCell SurvivalCellsClinicalCollagenDevelopmentDiseaseDisease ProgressionEducationEndothelial CellsEngineeringEnsureEnvironmentEnzymesExposure toExtracellular MatrixFamily suidaeFibroblastsFutureGlycosaminoglycansGrantHIVHistologyHumanHuman ResourcesHydrogelsImmunohistochemistryIn Situ HybridizationIn VitroInfectionInflammationInflammatoryInstitutionLaboratoriesMass Spectrum AnalysisMechanicsMediatingMediator of activation proteinMinority-Serving InstitutionModelingMyocarditisPathologicPathologyPatientsPhenotypePhysiologicalPhysiologyPopulationPreclinical TestingPredispositionProbabilityProteomicsRenin-Angiotensin SystemReportingResearchRespiratory FailureRoleSARS coronavirusSARS-CoV-2 infectionSARS-CoV-2 spike proteinSamplingSclerosisSeveritiesSignal TransductionSignaling MoleculeStructureStudent recruitmentStudentsSystemTechniquesTestingTherapeuticTissue BanksTissue MicroarrayTissuesTraining ProgramsUnderrepresented StudentsUniversitiesValidationViral Load resultWorkaortic valveaortic valve disorderbasecalcificationcareercomorbiditycytokinecytokine release syndromedesignefficacy testingexperienceexperimental studyhemodynamicshistological stainshuman diseaseinnovationinterstitial cellmortalitynovelprototypereceptorsevere COVID-19successundergraduate researchundergraduate studentviron
项目摘要
PROJECT SUMMARY
Recent reports have uncovered the role of angiotensin-converting enzyme 2 (ACE2) as the receptor for
mediating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into host cells. The aortic valve
is one specific tissue within the cardiovascular system that has robust expression of ACE2 and other renin-
angiotensin system (RAS) mediators. However, there are no studies that test if ACE2 or RAS expression in the
aortic valve increases the propensity for its robust infection by SARS-CoV-2. We also do not know if SARS-CoV-
2 infection probability increases if there is existing valve pathology in the patient. We hypothesize that altered
ACE2 expression and RAS signaling during calcific aortic valve disease (CAVD) progression potentiates
increased susceptibility to SARS-CoV-2 infection, and thereby further progression of valve pathology. This
hypothesis will be tested via the following three specific aims: Aim 1 focuses on studying the expression profile
of ACE2 and RAS signaling molecules at various stages of valve disease in human ex vivo valve sections. Aim
2 seeks to engineer and validate a three-dimensional human aortic valve tissue-chip that can mimic normal
(healthy) and diseased aortic valve leaflets. Aim 3 will test the ACE2-mediated effects of SARS-CoV-2 infection
on these valve-chip models to understand if valve pathological burden predisposes the valve to more severe
SARS-CoV-2 infection. We will also test the efficacy of ACE2 blockade as a potential therapeutic strategy. If the
proposed experiments are successful, this R15 grant will set the stage for future larger-scale preclinical testing
studies using our valve-chip to study the pathological effects of SARS-CoV-2 infection on the cardiovascular and
valve systems. The proposed studies are also intertwined with a robust research exposure plan for providing
meritorious research experiences to undergraduate students, with exposure to clinical perspectives via our
clinical collaborator Dr. Vallurupalli. We will draw from the diverse pool of undergraduates available at the
University of Arkansas, a minority-serving institution as designated by the Department of Education, including
students underrepresented in the biomedical research workforce.
项目摘要
最近的报道已经揭示了血管紧张素转换酶2(ACE 2)作为血管紧张素受体的作用。
介导严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入宿主细胞。主动脉瓣
是心血管系统内的一种特异性组织,其具有ACE 2和其他肾素-血管紧张素转换酶的稳健表达。
血管紧张素系统(RAS)介质。然而,还没有研究检测ACE 2或RAS表达是否在血管内皮细胞中,
主动脉瓣增加了其被SARS-CoV-2强烈感染的倾向。我们也不知道SARS-CoV-
如果患者存在瓣膜病变,则感染概率增加。我们假设
钙化性主动脉瓣疾病(CAVD)进展过程中ACE 2表达和RAS信号增强
增加对SARS-CoV-2感染的易感性,从而进一步发展瓣膜病理学。这
假设将通过以下三个具体目标进行测试:目标1侧重于研究表达谱
ACE 2和RAS信号分子在人离体瓣膜切片中瓣膜疾病不同阶段的表达。目的
2旨在设计和验证一种三维人体主动脉瓣组织芯片,
(健康的)和患病的主动脉瓣小叶。目的3检测ACE 2介导的SARS-CoV-2感染的效应
在这些瓣膜-芯片模型上,以了解瓣膜病理负荷是否使瓣膜更严重
SARS-CoV-2感染。我们还将测试ACE 2阻断作为潜在治疗策略的有效性。如果
建议的实验是成功的,这个R15赠款将为未来更大规模的临床前试验奠定基础
使用我们的瓣膜芯片研究SARS-CoV-2感染对心血管和
阀门系统拟议的研究还与一个强大的研究暴露计划交织在一起,
值得研究的经验,本科生,与接触的临床观点,通过我们的
临床合作者Vandalupalli博士。我们将从不同的本科生池中抽取,
阿肯色州大学,教育部指定的少数民族服务机构,包括
学生在生物医学研究队伍中的代表性不足。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kartik Balachandran其他文献
Kartik Balachandran的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
REU Site: Design, Create, and Innovate 3-Dimensional User Interfaces to Improve Human Sensory and Motor Performance in Virtual Environments (HUMANS MOVE)
REU 网站:设计、创建和创新 3 维用户界面,以提高虚拟环境中的人类感官和运动表现 (HUMANS MOVE)
- 批准号:
2349771 - 财政年份:2024
- 资助金额:
$ 43.66万 - 项目类别:
Standard Grant
CAREER: Atomic-level understanding of stability and transition kinetics of 3-dimensional interfaces under irradiation
职业:对辐照下 3 维界面的稳定性和转变动力学的原子水平理解
- 批准号:
2340085 - 财政年份:2024
- 资助金额:
$ 43.66万 - 项目类别:
Continuing Grant
Artificial fabrication of 3-dimensional noncollinear magnetic order and magnetization manipulation by spin torque
三维非共线磁序的人工制造和自旋转矩磁化操纵
- 批准号:
23H00232 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Understanding of 3-dimensional seismic behavior of RC frame high-speed railway/highway viaducts using FE analysis
使用有限元分析了解 RC 框架高速铁路/公路高架桥的 3 维抗震性能
- 批准号:
23H01489 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
- 批准号:
10736961 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
The 3-dimensional nest of the honey bee: organization, development, and impact on colony function
蜜蜂的 3 维巢穴:组织、发育及其对蜂群功能的影响
- 批准号:
2216835 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Standard Grant
Research on high-density 3-dimensional polymer optical waveguide device for photonics-electronics convergence
光电子融合高密度三维聚合物光波导器件研究
- 批准号:
23H01882 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Scaff-Net: 3 Dimensional multiphoton polymerisation printed scaffolds for medium throughput recording from stem cell derived human cortical networks.
Scaff-Net:3 维多光子聚合打印支架,用于从干细胞衍生的人类皮质网络进行中等通量记录。
- 批准号:
EP/X018385/1 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Research Grant
3-dimensional prompt gamma imaging for online proton beam dose verification
用于在线质子束剂量验证的 3 维瞬发伽马成像
- 批准号:
10635210 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Equipment: MRI: Track 1 Acquisition of a 3-Dimensional Nanolithography Instrument
设备:MRI:轨道 1 获取 3 维纳米光刻仪器
- 批准号:
2320636 - 财政年份:2023
- 资助金额:
$ 43.66万 - 项目类别:
Standard Grant